Home | Subscribe | Post a Job | Advertise | Contact
« A few recent Section 101 cases at the PTAB |
| Myriad Seeks to Enforce its BRCA1/BRCA2 Gene Patents »
Posted on Jul 09, 2013 at 05:30 PM | Permalink
| Save to del.icio.us
You can follow this conversation by subscribing to the comment feed for this post.
The comments to this entry are closed.
Jason Rantanen, Associate ProfessorUniversity of IowaCollege of LawSSRN Articles
Occasional guest posts by IP practitioners and academics